Bloating is NOT a documented adverse effect of Zetia (ezetimibe)
Based on FDA labeling and clinical trial data, bloating is not listed as an adverse effect of ezetimibe. The most commonly reported gastrointestinal side effect is diarrhea (4.1% vs 3.7% placebo), not bloating 1.
What the Evidence Shows
FDA-Approved Safety Profile
The FDA label for Zetia clearly documents adverse reactions from clinical trials involving 2,396 patients on monotherapy and 11,308 patients on combination therapy with statins 1. The documented adverse effects include:
Gastrointestinal effects:
- Diarrhea (4.1% monotherapy, 2.5% with statin)
- Abdominal pain (noted in post-marketing with bempedoic acid combinations) 2
- Nausea (post-marketing reports) 1
Most common adverse effects overall (≥2%):
- Upper respiratory tract infection (4.3%)
- Diarrhea (4.1%)
- Arthralgia (3.0%)
- Sinusitis (2.8%)
- Pain in extremities (2.7%)
- Fatigue (2.4%)
Clinical Trial Evidence
According to the 2022 ACC Expert Consensus, ezetimibe is described as "generally well tolerated" with adverse effects in monotherapy including upper respiratory tract infection, diarrhea, arthralgia, sinusitis, and pain in extremities—but bloating is conspicuously absent 2.
Multiple research reviews confirm this safety profile. A 2008 systematic review concluded that "adverse effects associated with ezetimibe use are few and mild" with an adverse-event profile "similar to placebo" 3, 4. A 2024 comprehensive review emphasizes ezetimibe's "favourable tolerability, with fewer side effects than statins" 5.
Clinical Interpretation
If a patient reports bloating while taking Zetia, consider these alternative explanations:
- Coincidental timing - Bloating is a common symptom with many causes unrelated to ezetimibe
- Concomitant medications - Check for bile acid sequestrants (which DO cause bloating and should be dosed 2-4 hours apart from ezetimibe) 2
- Dietary factors - Patients on cholesterol-lowering diets may have increased fiber intake
- Other gastrointestinal conditions requiring evaluation
Bottom Line
Ezetimibe does not cause bloating based on extensive clinical trial data and FDA labeling. If bloating occurs, investigate other causes rather than attributing it to ezetimibe. The medication's gastrointestinal side effect profile is limited primarily to mild diarrhea at rates barely above placebo 1.